DrugInfoSys

Nifedipine

Drug #515

.

Primary Characteristics

It is of Synthetic origin and belongs to Pyridine.

It belongs to Calcium L-channel antagonist pharmacological group on the basis of mechanism of action.

Molecular Weight: 346.3 · Solubility in Water: practically Insoluble · Solubility in Alcohol: sparingly soluble · Non-proprietary name: Nifedipine.

Molecular structure of Nifedipine

Pharmacokinetics

Absorption: Nifedipine has an oral bioavailability is 50% (±13%).

Distribution: Nifedipine has a volume of distribution is 0.75 l/kg. plasma protein binding is > 90 %.

Elimination: it is metabolised via Hepatic, plasma half-life is 4 hr, renal excretion is 80 %.

Advertisement

Indications

Contraindications

Nifedipine is contraindicated in conditions like Diabetes mellitus, Cardiac insufficiency, Hypotension.

Dosage

Nifedipine's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
25 mg25 mgEvery 12hPO
Paediatric Dosage (20kg)
0.187 mg/kg0.187 mg/kgEvery 8hOral -
Neonatal Dosage (3kg)
0.187 mg/kg0.187 mg/kgEvery 8hOral -

Drug Interactions

Unknown9 interactions
7 interactions
Minor2 interactions
Moderate6 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Nifedipine in overdosage may give rise to further complications which include Flushing , Dizziness , Exacerbated angina.

Nifedipine produces potentially life-threatening effects which include Cardiovascular collapse. Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Nifedipine are Bradycardia, Hypotension, Unconsciousness.

Nifedipine is known to cause more or less tolerable side effects which are usually transient. These include Ankle swelling, GI upset, Headache, Palpitation, Paresthesias, Reversible Gingival HyperplasiaX.

Warnings / Precautions

Nifidipine should be used with caution in patients with kidney or liver disease. Consider decrease in dose of calcium channel blockers & monitor drug response in cirrhosis patients.

Interference in Pathology

Nifedipine may interfere in the diagnosis of Urinary Catecholamines Metabolite Assay .

Available Brands

Click on a strength to view available brands.

Single Ingredient

Storage Conditions

Nifedipine should be stored Caps.

Drug Classification

  1. 1.12.3.2Calcium antagonists

Manufacturers